跳至主要内容
临床试验/NCT03775239
NCT03775239已完成不适用

Mindfulness as Treatment of Sexological Problems: A Randomized, Controlled Pilot Study of Mindfulness in Sex Therapy and Intimate Relationships (MSIR) in the Treatment of Sexual Dysfunctions

Mental Health Services in the Capital Region, Denmark2 个研究点 分布在 1 个国家目标入组 34 人开始时间: 2018年7月25日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
34
试验地点
2
主要终点
The Sexual Function Questionnaire for Females & Males (CSFQ-14-F/M)

研究概览

简要总结

The primary aim of this study is to test Mindfulness in Sex Therapy and Intimate Relationships (MSIR) as an add-on treatment to sex therapy in a clinical sample of patients referred with sexual problems, controlling for time effect, with a treatment as usual activity group.

The secondary aim is to investigate the effect of MSIR alone on sexual dysfunction compared to treatment-as-usual (TAU).

It is hypothesized that the MSIR group, in preceding the usual TAU intervention, will achieve greater benefits in relation to sexual functioning outcomes as measured by subjective and objective measures. The investigators expect that MSIR will help the patients to cultivate accept and body awareness, which will create a wider sense of safety and stability that might help integrating the assistant provided by the traditional approach to the treatment of sexual dysfunctions. It is hypothesized that the intervention (MSIR+TAU) reduces the amount of TAU sessions needed in order to achieve a benefit in terms of the patient's sexual dysfunction.

It is furthermore, hypothesized that the intervention (MSIR) alone will have a positive effect on the sexual dysfunction.

The research project outlines a pragmatic pilot randomized control trial to evaluate MSIR treatment as an add-on to the treatment-as-usual (TAU) compared to TAU for sexual difficulties in men and women.

详细描述

BACKGROUND:

Prevalence of sexual dysfunction is high, although estimates are variable. For men, the reported level of sexual difficulty, taking all conditions into account, is around 33% or up to 46%. For women, the reported level of sexual difficulty is higher, with estimates up to around 66%. Sexual dysfunctions are associated with a negative impact on the quality of life in both men and women and there is therefore a need for effective treatments.

AIM:

The primary aim of this study is to test Mindfulness in Sex Therapy and Intimate Relationships (MSIR) as an add-on treatment to sex therapy in a clinical sample of patients referred with sexual problems, controlling for time effect, with a treatment as usual activity group.

The secondary aim is to investigate the effect of MSIR alone on sexual dysfunction compared to treatment-as-usual (TAU).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
20 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients aged 20-65 years referred to Sexological Clinic and diagnosed with sexual dysfunction (desire dysfunction, erectile dysfunction, orgasm dysfunction, sexual pain or hyper sexuality).
  • After assessment, being allocated to individual or couple therapy for their sexual dysfunction. The partner will be included in case of couples therapy
  • Allocated to a minimum of 6 treatment sessions in TAU after assessment
  • Giving informed consent
  • Being able to read, write, speak and understand the Danish language.

排除标准

  • Assessed for group therapy
  • Cannot participate at the scheduled MSIR session due for practical reasons
  • Having experienced sexual trauma in the past, suffering from mental illness, severe somatic disease and/or addiction
  • Withdrawing their informed consent

结局指标

主要结局

The Sexual Function Questionnaire for Females & Males (CSFQ-14-F/M)

时间窗: Change from baseline CSFQ score to 6 month follow-up CSFQ score

The CSFQ is a 14 item self-report inventory which measures sexual functioning on a 5 point likert scale. The questionnaire comprises: a 5 scale structure consistent with the original (longer) CSFQ - Desire/Frequency, Desire/Interest, Arousal/Excitement, Orgasm/Completion, Pleasure, The questionnaire has a high degree of internal consistency as a whole (Cronbach's alpha = 0.90 for females and 0.89 for males) and for the individual scales (all were between 0.68 and 0.84, except the male orgasm/completion scale, 0.59). Good scale coherency and discrimination was demonstrated by highly significant mean difference scores between the CSFQ and control groups.

Bothered by Problem (VAS)

时间窗: Change from baseline VAS score to 6 month follow-up VAS score

Single-item distress scale measuring on a Likert scale from 1-10 (10 is most distressed) distress by the problem which the person sought help for. "How bothered are you at this time of the problem you are/were seeking for help for?"

The International Index of Erectile Function (IIEF)

时间窗: Change from baseline IIEF score to 6 month follow-up IIEF score

The IIEF is a validated self-administered 15-item questionnaire that asses male sexual function. The IIEF-questionnaire seeks to detect treatment-related changes in patients with erectile functions and is the golden standard. The IIEF comprises a full scale and five subdomains (erectile function, orgasmic function, sexual desire, intercourse satisfaction and overall satisfaction). A low score represents worse sexual function. The questionnaire comprises a full scale and five subdomains. The subdomains are; erectile function; orgasmic function; sexual desire; intercourse satisfaction; and overall satisfaction).

Female Sexual Function Index (FSFI)

时间窗: Change from baseline FSFI score to 6 month follow-up FSFI score

The Female Sexual Function Index (FSFI) is a validated 19-item multidimensional self-report instrument for the assessment of female sexual function that comprise a full scale and six subscales (desire, arousal, lubrication, orgasm, satisfaction and pain). It measures the overall sexual function through either 0-5 or 1-5-point Likert scales. A higher score represents better sexual function. A score equal to or below 26.55 points represents a risk of sexual dysfunction. The FSFI has shown test-retest reliability (r=0,75-0,86). The scale is recommended for clinical practice as a measure of symptoms severity in women who have been sexually active in the prior 4 weeks51 and is the golden standard when measuring sexual function in women

Female Sexual Distress Scale (FSDS)

时间窗: Change from baseline FSDS score to 6 month follow-up FSDS score

The Female Sexual Distress Scale (FSDS) is a validated 12-item self-administered questionnaire, developed to measure sexually related personal distress in women. Lower scores represent less sexual distress. Scores equal to or above 15 points indicates sexually related distress.

次要结局

  • The Multidimensional Assessment of Interoceptive Awareness (MAIA)(Week 0, week 3,6,9,month 6)
  • The Five Facet Mindfulness Questionnaire (FFMQ)(1 time a week after mindfulness session up to 8 weeks)
  • World Health Organization 5 Wellbeing Questionnaire (WHO-5)(Week 0, week 3,6,9,month 6)
  • The Symptom Checklist (SCL-10)(Week 0, week 3,6,9,month 6)

研究者

发起方
Mental Health Services in the Capital Region, Denmark
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验